Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nicholson

Showing results (201-210 of 395) with videos related to

Pageof 40
Sort By:
Journal of Medicinal Chemistry|January 17, 2009
The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptorBerthold Wroblowski, Mark J Wigglesworth, Philip G Szekeres, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 12, 2003
Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsyDavid J Winchester, Joel R Bernstein, Jan M Jeske, et al.
Molecular Cancer Therapeutics|October 14, 2025
Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinomaKaty L Swancutt, Eslam A Elghonaimy, James H Nicholson, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinomaKaty L Swancutt, Eslam A Elghonaimy, James H Nicholson, et al.
The Journal of Antibiotics|December 1, 1996
Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistryG Burton, G J Clarke, J D Douglas, et al.
NPJ Precision Oncology|January 17, 2025
Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancerBrock J Sishc, Janapriya Saha, Elizabeth M Alves, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB(2) agonists for the treatment of inflammatory painRobert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndromeMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.
JAMA|February 26, 2020
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing ScreeningChristopher E Comstock, Constantine Gatsonis, Gillian M Newstead, et al.
Physical Review Letters|February 7, 2003
n-p short-range correlations from (p,2p+n) measurementsA Tang, J W Watson, J Aclander, et al.
Pageof 40

Showing results (201-210 of 395) with videos related to

Sort By:
Pageof 40
Journal of Medicinal Chemistry|January 17, 2009
The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptorBerthold Wroblowski, Mark J Wigglesworth, Philip G Szekeres, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 12, 2003
Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsyDavid J Winchester, Joel R Bernstein, Jan M Jeske, et al.
Molecular Cancer Therapeutics|October 14, 2025
Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinomaKaty L Swancutt, Eslam A Elghonaimy, James H Nicholson, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinomaKaty L Swancutt, Eslam A Elghonaimy, James H Nicholson, et al.
The Journal of Antibiotics|December 1, 1996
Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistryG Burton, G J Clarke, J D Douglas, et al.
NPJ Precision Oncology|January 17, 2025
Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancerBrock J Sishc, Janapriya Saha, Elizabeth M Alves, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB(2) agonists for the treatment of inflammatory painRobert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndromeMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.
JAMA|February 26, 2020
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing ScreeningChristopher E Comstock, Constantine Gatsonis, Gillian M Newstead, et al.
Physical Review Letters|February 7, 2003
n-p short-range correlations from (p,2p+n) measurementsA Tang, J W Watson, J Aclander, et al.
Pageof 40